Development of a Diphtheria Toxin Based Antiporcine CD3 Recombinant Immunotoxin

详细信息    查看全文

• 作者：Zhirui Wang ; Raimon Duran-Struuck ; Rebecca Crepeau ; Abraham Matar ; Isabel Hanekamp ; Srimathi Srinivasan ; David M. Neville ; Jr. ; David H. Sachs ; Christene A. Huang
• 刊名：Bioconjugate Chemistry
• 出版年：2011
• 出版时间：October 19, 2011
• 年：2011
• 卷：22
• 期：10
• 页码：2014-2020
• 全文大小：853K
• 年卷期：v.22,no.10(October 19, 2011)
• ISSN：1520-4812

文摘

Anti-CD3 immunotoxins, which induce profound but transient T-cell depletion in vivo by inhibiting eukaryotic protein synthesis in CD3+ cells, are effective reagents in large animal models of transplantation tolerance and autoimmune disease therapy. A diphtheria toxin based antiporcine CD3 recombinant immunotoxin was constructed by fusing the truncated diphtheria toxin DT390 with two identical tandem single chain variable fragments (scFv) derived from the antiporcine CD3 monoclonal antibody 898H2鈥?鈥?5. The recombinant immunotoxin was expressed in a diphtheria-toxin resistant yeast Pichia pastoris strain under the control of the alcohol oxidase promoter. The secreted recombinant immunotoxin was purified sequentially with hydrophobic interaction chromatography (Butyl 650 M) followed by strong anion exchange (Poros 50 HQ). The purified antiporcine CD3 immunotoxin was tested in vivo in four animals; peripheral blood CD3+ T-cell numbers were reduced by 80% and lymph node T-cells decreased from 74% CD3+ cells pretreatment to 24% CD3+ cells remaining in the lymph node following 4 days of immunotoxin treatment. No clinical toxicity was observed in any of the experimental swine. We anticipate that this conjugate will provide an important tool for in vivo depletion of T-cells in swine transplantation models.